Goldman Sachs Maintains Neutral on Pfizer (PFE) Amid Rising Margin Pressure

1 day ago 3

Sheryar Siddiq

Tue, February 3, 2026 astatine 4:12 AM CST 1 min read

Pfizer Inc. (NYSE:PFE) ranks among the stocks with the lowest guardant PE ratios. On January 23, Goldman Sachs reaffirmed its Neutral standing and $26 terms people connected Pfizer Inc. (NYSE:PFE), citing the pharma giant’s cardinal hurdles. Pfizer is facing the archetypal of 3 years of rising patent-cliff strain connected its nett margins, arsenic its concern improvement capableness has been slashed to $6 cardinal and dividend maturation has stagnated for the precise archetypal clip successful 16 years.

Pixabay/Public Domain

According to Goldman Sachs, a terms rebound volition astir apt beryllium driven by 2026 objective catalysts, with investors focusing particularly connected obesity updates fixed Pfizer’s caller MTSR acquisition, which puts the institution backmost successful the value nonaccomplishment therapy race.

The coming VESPER-3 monthly data, which could beryllium released successful the archetypal fractional of 2026 alternatively of the archetypal quarter, arsenic primitively said, is expected to beryllium the astir important temper operator for PFE shares this year.

Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products successful the US and internationally. The institution offers medicines and vaccines successful assorted therapeutic areas.

While we admit the imaginable of PFE arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.